Clinical evaluation of potential usefulness of CEA, CA 15-3, and MCA in follow-up of breast cancer patients
References (40)
- et al.
CA 15-3, TPA and MCA as markers for breast cancer
Eur. J. Cancer
(1990) - et al.
Clinical value of a mucin-like carcinoma-associated antigen in monitoring breast cancer patients in comparison with CA 15-3
Eur. J. Cancer
(1991) Serum CEA in the diagnosis and prognosis of women with breast cancer
Cancer
(1984)Clinical applications of serum tumor markers
Ann. Intern. Med.
(1991)- et al.
Preliminary study on serum levels of mucinous-like cancer antigen (MCA) in patients with breast cancer disease: comparison with CEA
Int. J. Biol. Markers
(1991) - et al.
Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic disease
Cancer
(1989) - et al.
A new tumor marker MCA in breast cancer diagnosis
Anticancer Res.
(1988) - et al.
Use of tumor markers CA 15-3, MCA and CEA in breast cancer diagnostics
J. Tumor Mar. Oncol.
(1989) - et al.
The diagnostic value of CA 27-29, CA 15-3, mucin-like carcinoma antigen, carcinoembryonic antigen and CA 19-9 in breast and gastrointestinal malignancies
Tumor Biol.
(1994) - et al.
The tumor associated antigen CA 15-3 in primary breast cancer
Br. J. Cancer
(1991)
Demonstration of tumorspecific antigens in human colonic carcinoma by immunological tolerance and adsorption techniques
J. Exp. Med.
(1965)
Carcinoembryonic antigen: its role as a marker in the management of cancer
J. Cancer Res. Clin. Oncol.
(1981)
Cancer of the breast
Comparison of circulating CA 15-3 and carcinoembryonic antigen levels in patients with breast cancer
J. Clin. Oncol.
(1986)
Breast cancer
MAM-6, a new serum marker for breast cancer monitoring
Cancer Res.
(1986)
The early detection of disseminated (metastasized) breast cancer by serial tumor marker measurements
Eur. J. Cancer Prev.
(1993)
Tumormarker. Der derzeitige diagnostische Stand
Wien. Med. Wochenschr.
(1988)
Differential reactivity of a novel monoclonal antibody (DF3) with human versus benign breast tumors
Hybridoma
(1984)
Use of mucin like cancer associated antigen (MCA) in the management of breast cancer
Br. J. Cancer
(1991)
Cited by (0)
Copyright © 1996 Published by Elsevier Ireland Ltd.